RecallDepth
Class III Terminated

FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4297-31, UPC 3 0054-4297-31 8.

Company
Boehringer Ingelheim Roxane Inc
Recall Initiated
September 25, 2015
Posted
October 21, 2015
Recall Number
D-0011-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
11,110 bottles
Firm Location
Columbus, OH, United States

Reason for Recall

CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: 559660P, 559661P, Exp 03/17

More recalls by Boehringer Ingelheim Roxane Inc

View all recalls by this company →

Other recent Class III Drug recalls